table of content
1 Study Coverage
1.1 Human Hepatitis B Immunoglobulin Product Introduction
1.2 Global Human Hepatitis B Immunoglobulin Outlook 2017 VS 2022 VS 2028
1.2.1 Global Human Hepatitis B Immunoglobulin Sales in US$ Million for the Year 2017-2028
1.2.2 Global Human Hepatitis B Immunoglobulin Sales in Volume for the Year 2017-2028
1.3 United States Human Hepatitis B Immunoglobulin Outlook 2017 VS 2022 VS 2028
1.3.1 United States Human Hepatitis B Immunoglobulin Sales in US$ Million for the Year 2017-2028
1.3.2 United States Human Hepatitis B Immunoglobulin Sales in Volume for the Year 2017-2028
1.4 Human Hepatitis B Immunoglobulin Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.4.1 The Market Share of United States Human Hepatitis B Immunoglobulin in Global, 2017 VS 2022 VS 2028
1.4.2 The Growth Rate of Human Hepatitis B Immunoglobulin Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.5 Human Hepatitis B Immunoglobulin Market Dynamics
1.5.1 Human Hepatitis B Immunoglobulin Industry Trends
1.5.2 Human Hepatitis B Immunoglobulin Market Drivers
1.5.3 Human Hepatitis B Immunoglobulin Market Challenges
1.5.4 Human Hepatitis B Immunoglobulin Market Restraints
1.6 Study Objectives
1.7 Years Considered
2 Market by Type
2.1 Human Hepatitis B Immunoglobulin Market Segment by Type
2.1.1 100IU/Bottle Human Hepatitis B Immunoglobulin (HBIG)
2.1.2 200IU/Bottle Human Hepatitis B Immunoglobulin (HBIG)
2.1.3 400IU/Bottle Human Hepatitis B Immunoglobulin (HBIG)
2.2 Global Human Hepatitis B Immunoglobulin Market Size by Type
2.2.1 Global Human Hepatitis B Immunoglobulin Sales in Value, by Type (2017, 2022 & 2028)
2.2.2 Global Human Hepatitis B Immunoglobulin Sales in Volume, by Type (2017, 2022 & 2028)
2.2.3 Global Human Hepatitis B Immunoglobulin Average Selling Price (ASP) by Type (2017, 2022 & 2028)
2.3 United States Human Hepatitis B Immunoglobulin Market Size by Type
2.3.1 United States Human Hepatitis B Immunoglobulin Sales in Value, by Type (2017, 2022 & 2028)
2.3.2 United States Human Hepatitis B Immunoglobulin Sales in Volume, by Type (2017, 2022 & 2028)
2.3.3 United States Human Hepatitis B Immunoglobulin Average Selling Price (ASP) by Type (2017, 2022 & 2028)
3 Market by Application
3.1 Human Hepatitis B Immunoglobulin Market Segment by Application
3.1.1 Hepatitis B Carrier
3.1.2 Hepatitis B Close Contacts
3.2 Global Human Hepatitis B Immunoglobulin Market Size by Application
3.2.1 Global Human Hepatitis B Immunoglobulin Sales in Value, by Application (2017, 2022 & 2028)
3.2.2 Global Human Hepatitis B Immunoglobulin Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 Global Human Hepatitis B Immunoglobulin Average Selling Price (ASP) by Application (2017, 2022 & 2028)
3.3 United States Human Hepatitis B Immunoglobulin Market Size by Application
3.3.1 United States Human Hepatitis B Immunoglobulin Sales in Value, by Application (2017, 2022 & 2028)
3.3.2 United States Human Hepatitis B Immunoglobulin Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 United States Human Hepatitis B Immunoglobulin Average Selling Price (ASP) by Application (2017, 2022 & 2028)
4 Global Human Hepatitis B Immunoglobulin Competitor Landscape by Company
4.1 Global Human Hepatitis B Immunoglobulin Market Size by Company
4.1.1 Top Global Human Hepatitis B Immunoglobulin Manufacturers Ranked by Revenue (2021)
4.1.2 Global Human Hepatitis B Immunoglobulin Revenue by Manufacturer (2017-2022)
4.1.3 Global Human Hepatitis B Immunoglobulin Sales by Manufacturer (2017-2022)
4.1.4 Global Human Hepatitis B Immunoglobulin Price by Manufacturer (2017-2022)
4.2 Global Human Hepatitis B Immunoglobulin Concentration Ratio (CR)
4.2.1 Human Hepatitis B Immunoglobulin Market Concentration Ratio (CR) (2017-2022)
4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Human Hepatitis B Immunoglobulin in 2021
4.2.3 Global Human Hepatitis B Immunoglobulin Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Human Hepatitis B Immunoglobulin Manufacturing Base Distribution, Product Type
4.3.1 Global Human Hepatitis B Immunoglobulin Manufacturers, Headquarters and Distribution of Producing Region
4.3.2 Manufacturers Human Hepatitis B Immunoglobulin Product Type
4.3.3 Date of International Manufacturers Enter into Human Hepatitis B Immunoglobulin Market
4.4 Manufacturers Mergers & Acquisitions, Expansion Plans
4.5 United States Human Hepatitis B Immunoglobulin Market Size by Company
4.5.1 Top Human Hepatitis B Immunoglobulin Players in United States, Ranked by Revenue (2021)
4.5.2 United States Human Hepatitis B Immunoglobulin Revenue by Players (2020, 2021 & 2022)
4.5.3 United States Human Hepatitis B Immunoglobulin Sales by Players (2020, 2021 & 2022)
5 Global Human Hepatitis B Immunoglobulin Market Size by Region
5.1 Global Human Hepatitis B Immunoglobulin Market Size by Region: 2017 VS 2022 VS 2028
5.2 Global Human Hepatitis B Immunoglobulin Market Size in Volume by Region (2017-2028)
5.2.1 Global Human Hepatitis B Immunoglobulin Sales in Volume by Region: 2017-2022
5.2.2 Global Human Hepatitis B Immunoglobulin Sales in Volume Forecast by Region (2023-2028)
5.3 Global Human Hepatitis B Immunoglobulin Market Size in Value by Region (2017-2028)
5.3.1 Global Human Hepatitis B Immunoglobulin Sales in Value by Region: 2017-2022
5.3.2 Global Human Hepatitis B Immunoglobulin Sales in Value by Region: 2023-2028
6 Segment in Region Level & Country Level
6.1 North America
6.1.1 North America Human Hepatitis B Immunoglobulin Market Size YoY Growth 2017-2028
6.1.2 North America Human Hepatitis B Immunoglobulin Market Facts & Figures by Country (2017, 2022 & 2028)
6.1.3 U.S.
6.1.4 Canada
6.2 Asia-Pacific
6.2.1 Asia-Pacific Human Hepatitis B Immunoglobulin Market Size YoY Growth 2017-2028
6.2.2 Asia-Pacific Human Hepatitis B Immunoglobulin Market Facts & Figures by Region (2017, 2022 & 2028)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 China Taiwan
6.2.9 Indonesia
6.2.10 Thailand
6.2.11 Malaysia
6.3 Europe
6.3.1 Europe Human Hepatitis B Immunoglobulin Market Size YoY Growth 2017-2028
6.3.2 Europe Human Hepatitis B Immunoglobulin Market Facts & Figures by Country (2017, 2022 & 2028)
6.3.3 Germany
6.3.4 France
6.3.5 U.K.
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America Human Hepatitis B Immunoglobulin Market Size YoY Growth 2017-2028
6.4.2 Latin America Human Hepatitis B Immunoglobulin Market Facts & Figures by Country (2017, 2022 & 2028)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.5 Middle East and Africa
6.5.1 Middle East and Africa Human Hepatitis B Immunoglobulin Market Size YoY Growth 2017-2028
6.5.2 Middle East and Africa Human Hepatitis B Immunoglobulin Market Facts & Figures by Country (2017, 2022 & 2028)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 UAE
7 Company Profiles
7.1 Baxter
7.1.1 Baxter Corporation Information
7.1.2 Baxter Description and Business Overview
7.1.3 Baxter Human Hepatitis B Immunoglobulin Sales, Revenue and Gross Margin (2017-2022)
7.1.4 Baxter Human Hepatitis B Immunoglobulin Products Offered
7.1.5 Baxter Recent Development
7.2 CSL
7.2.1 CSL Corporation Information
7.2.2 CSL Description and Business Overview
7.2.3 CSL Human Hepatitis B Immunoglobulin Sales, Revenue and Gross Margin (2017-2022)
7.2.4 CSL Human Hepatitis B Immunoglobulin Products Offered
7.2.5 CSL Recent Development
7.3 Bayer
7.3.1 Bayer Corporation Information
7.3.2 Bayer Description and Business Overview
7.3.3 Bayer Human Hepatitis B Immunoglobulin Sales, Revenue and Gross Margin (2017-2022)
7.3.4 Bayer Human Hepatitis B Immunoglobulin Products Offered
7.3.5 Bayer Recent Development
7.4 Grifols
7.4.1 Grifols Corporation Information
7.4.2 Grifols Description and Business Overview
7.4.3 Grifols Human Hepatitis B Immunoglobulin Sales, Revenue and Gross Margin (2017-2022)
7.4.4 Grifols Human Hepatitis B Immunoglobulin Products Offered
7.4.5 Grifols Recent Development
7.5 Octapharma
7.5.1 Octapharma Corporation Information
7.5.2 Octapharma Description and Business Overview
7.5.3 Octapharma Human Hepatitis B Immunoglobulin Sales, Revenue and Gross Margin (2017-2022)
7.5.4 Octapharma Human Hepatitis B Immunoglobulin Products Offered
7.5.5 Octapharma Recent Development
7.6 Shanghai RAAS
7.6.1 Shanghai RAAS Corporation Information
7.6.2 Shanghai RAAS Description and Business Overview
7.6.3 Shanghai RAAS Human Hepatitis B Immunoglobulin Sales, Revenue and Gross Margin (2017-2022)
7.6.4 Shanghai RAAS Human Hepatitis B Immunoglobulin Products Offered
7.6.5 Shanghai RAAS Recent Development
7.7 Hualan Biological
7.7.1 Hualan Biological Corporation Information
7.7.2 Hualan Biological Description and Business Overview
7.7.3 Hualan Biological Human Hepatitis B Immunoglobulin Sales, Revenue and Gross Margin (2017-2022)
7.7.4 Hualan Biological Human Hepatitis B Immunoglobulin Products Offered
7.7.5 Hualan Biological Recent Development
7.8 China Biologic
7.8.1 China Biologic Corporation Information
7.8.2 China Biologic Description and Business Overview
7.8.3 China Biologic Human Hepatitis B Immunoglobulin Sales, Revenue and Gross Margin (2017-2022)
7.8.4 China Biologic Human Hepatitis B Immunoglobulin Products Offered
7.8.5 China Biologic Recent Development
7.9 Tiantan Biologic
7.9.1 Tiantan Biologic Corporation Information
7.9.2 Tiantan Biologic Description and Business Overview
7.9.3 Tiantan Biologic Human Hepatitis B Immunoglobulin Sales, Revenue and Gross Margin (2017-2022)
7.9.4 Tiantan Biologic Human Hepatitis B Immunoglobulin Products Offered
7.9.5 Tiantan Biologic Recent Development
7.10 Shuanglin Bio-pharmacy
7.10.1 Shuanglin Bio-pharmacy Corporation Information
7.10.2 Shuanglin Bio-pharmacy Description and Business Overview
7.10.3 Shuanglin Bio-pharmacy Human Hepatitis B Immunoglobulin Sales, Revenue and Gross Margin (2017-2022)
7.10.4 Shuanglin Bio-pharmacy Human Hepatitis B Immunoglobulin Products Offered
7.10.5 Shuanglin Bio-pharmacy Recent Development
7.11 Sichuan Yuanda Shuyang
7.11.1 Sichuan Yuanda Shuyang Corporation Information
7.11.2 Sichuan Yuanda Shuyang Description and Business Overview
7.11.3 Sichuan Yuanda Shuyang Human Hepatitis B Immunoglobulin Sales, Revenue and Gross Margin (2017-2022)
7.11.4 Sichuan Yuanda Shuyang Human Hepatitis B Immunoglobulin Products Offered
7.11.5 Sichuan Yuanda Shuyang Recent Development
7.12 Boya Bio-pharmaceutical
7.12.1 Boya Bio-pharmaceutical Corporation Information
7.12.2 Boya Bio-pharmaceutical Description and Business Overview
7.12.3 Boya Bio-pharmaceutical Human Hepatitis B Immunoglobulin Sales, Revenue and Gross Margin (2017-2022)
7.12.4 Boya Bio-pharmaceutical Products Offered
7.12.5 Boya Bio-pharmaceutical Recent Development
7.13 Shanghai Institute of Biological
7.13.1 Shanghai Institute of Biological Corporation Information
7.13.2 Shanghai Institute of Biological Description and Business Overview
7.13.3 Shanghai Institute of Biological Human Hepatitis B Immunoglobulin Sales, Revenue and Gross Margin (2017-2022)
7.13.4 Shanghai Institute of Biological Products Offered
7.13.5 Shanghai Institute of Biological Recent Development
8 Industry Chain and Sales Channels Analysis
8.1 Human Hepatitis B Immunoglobulin Industry Chain Analysis
8.2 Human Hepatitis B Immunoglobulin Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Human Hepatitis B Immunoglobulin Distributors
8.3 Human Hepatitis B Immunoglobulin Production Mode & Process
8.4 Human Hepatitis B Immunoglobulin Sales and Marketing
8.4.1 Human Hepatitis B Immunoglobulin Sales Channels
8.4.2 Human Hepatitis B Immunoglobulin Distributors
8.5 Human Hepatitis B Immunoglobulin Customers
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
